Global Radiation Oncology Market Overview:
Radiation oncology is a medical specialty which includes the controlled use of radiation to treat cancer either to reduce pain or for treatment and other symptoms caused by cancer. A radiation therapy also known as radiotherapy is the term used to define the actual treatment delivered by the radiation oncology team. Radiation therapy can be applied safely to an extensive range of cancers and may be used alone or in combination with surgery, chemotherapy and other treatments. Furthermore, it is completely non-invasive and accessed through out-patient clinics. Some of the key players profiled in the study are Varian Medical Systems (United States), Elekta AB (Sweden), Accuray Incorporated (United States), Ion Beam Applications SA (Belgium), C.R. Bard, Inc. (United States), Isoray Medical, Inc. (United States), Mevion Medical Systems, Inc. (United States), Nordian Inc. (Canada), NTP Radioisotopes (South Africa) and eviCore (United States).
On the basis of geography, the market of Radiation Oncology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Image-Guided Radiation Therapy (IGRT) will boost the Radiation Oncology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Radiation Oncology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Incidence of Cancer Worldwide
- Growing Elderly Population across the Globe
- Advancement in Technology of Radiation Oncology
- High Cost Related To Instrument and Therapy
- Increasing Adoption of Non-Invasive Procedures in Emerging Economies
- Lack of Trained Specialists in Developing Countries
On April 16, 2019 - Isoray, Inc., a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, has announced a new training collaboration with Texas Oncology. The collaboration brings together the innovators in internal radiation therapy (brachytherapy) to develop a program focused on training the next generation of brachytherapists. and On January 28, 2019 - Accuray Asia Limited, a subsidiary of Accuray Incorporated, and CNNC High Energy Equipment (Tianjin) Co., Ltd, a subsidiary of China Isotope and Radiation Corporation, has announced the formation of a joint venture to manufacture and sell radiation oncology systems in China.
Target Audience:Radiation Oncology Therapy Providers, Manufacturers of Medical Devices, Suppliers of Raw Materials, Healthcare Industry, Governmental Bodies and Research Firms
Major Objectives Focused through this Study To define, describe, and forecast the Global Radiation Oncology market on the basis of product [External Beam Radiation Therapy, Brachytherapy, Systemic Beam Radiation Therapy and Others] , application [Blood Cancer (Leukaemia), Breast Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Skin Cancer and Other], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Radiation Oncology market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Radiation Oncology industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are CIVCO Radiotherapy (United States) and Bionix Radiation Therapy (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Radiation Oncology market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.